| IPO Company Profile |
| SEC Filings | Peer IPO Companies |
| Dey, Inc. |
| 2751 Napa Valley Corporate Drive, Napa, CA 94558 * (877) 666-1534 |
| The company is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases and respiratory related allergies. |
| Manager | Tier | Phone |
| Bear, Stearns & Co. Inc. | Lead Manager | (212) 272-4850 |
| Hambrecht & Quist Incorporated | Co-manager | (415) 439-3626 |
| J.P. Morgan Securities Inc. | Co-manager | (212) 648-0517 |
| Lehman Brothers Incorporated | Co-manager | (212) 526-8100 |
| NASNTL: | DYY | Manufacturing: | SIC 2834 | |
| Type of Shares: | Common Shares | Filing Date: | 7/24/98 | |
| U.S. Shares Filed: | 14,100,000 | Filing Range: | $12.00 - $16.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $197,400,000 | |
| Primary Shares: | 14,100,000 | Expenses: | - | |
| Secondary Shares: | 0 | Post-IPO Shares: | 86,985,000 | |
| Employees: | 663 |
| Issuer's Law Firm: | Coudert Brothers |
| Bank's Law Firm: | Skadden, Arps, Slate, Meagher & Flom |
| Registrar/Transfer Agent: | American Stock Transfer & Trust Co |
| Auditor: | KPMG Peat Marwick |
Dollar amounts in U.S. millions except for per share data | |||||
| 3 Month Ending Financials | |||||
| Full Year Audited Income | Latest Unaudited Income | Prior Audited Income | Balance Sheet | ||
| 12/31/97 | 3/31/98 | 3/31/97 | 3/31/98 | ||
| Revenue: | $219.80 | $71.10 | $52.30 | Assets: | $202.60 |
| Net Income: | $54.00 | $19.90 | $15.90 | Curr Assets: | $92.78 |
| EPS: | $0.74 | $0.27 | $0.22 | Liabilities: | $72.60 |
| Prior EPS: | $0.49 | Curr Liab: | $48.74 | ||
| Cash Flow/Oper: | $55.98 | $28.50 | $14.54 | Equity: | $130.00 |
| Cash Flow/Fin: | -$25.00 | -$13.90 | -$6.25 | Cash: | $38.20 |
| Cash Flow/Inv: | -$18.09 | $4.98 | -$2.97 | Working Cap: | $44.03 |
| Use of Proceeds |
| The proceeds from the proposed offering will be used to repay indebtedness of the company to an affiliate. |
| Name of Shareholder | % Owned Before | % Owned After |
| Lipha Americas Inc. | 1.00 | 0.84 |